HIMS Stock Sinks as FDA Gives Hims & Hers Peptide the Cold Shoulder

Source Summary

Hims & Hers shares crash as FDA panel votes against emideltide’s addition to the 503A Bulks List. Here’s what the news means for HIMS stock.